Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 228-235

  van Assen, Sander ^a   Holvast, Albert ^a   Telgt, Denise S C ^c   Benne, Cornelis A ^b   de Haan, Aalzen ^a   Westra, Johanna ^a   Kallenberg, Cees G M ^a   Bijl, Marc ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Laboratory for Infectious Diseases   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Common variable immunodeficiency; Hypogammaglobulinemia; Influenza vaccination; IVIg

Indexed keywords

INFLUENZA VACCINE; TRIVALENT INFLUENZA SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEMAGGLUTINATION TEST; HUMAN; HUMORAL IMMUNE DEFICIENCY; INJECTION SITE INDURATION; MALE; MYALGIA; PRIORITY JOURNAL; SEASONAL INFLUENZA; TREATMENT RESPONSE; VACCINATION; VIRUS STRAIN;

ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; VACCINES, SUBUNIT;

EID: 77954315985     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.03.430     Document Type: Article

References (24)

1. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2006, 55:1-42.
2. Treanor J.J. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases 2005, Elsevier, Philadelphia. sixth ed.
3. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2006, 55:1-42.
4. Yarchoan R., Schneider H.S., Wray B.B., Nelson D.L. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia. J. Clin. Invest. 1983, 71:1720-1727.
5. Goldacker S., Draeger R., Warnatz K., Huzly D., Salzer U., Thiel J., et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin. Immunol. 2007, 124:294-303.
6. de Jong J.C., Rimmelzwaan G.F., Donker G.A., Meijer A., Fouchier R.A., Osterhaus A.D. The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season. Ned Tijdschr Geneeskd 2007, 151:2158-2165.
7. Harmon M.W. Influenza viruses. Laboratory Diagnosis of Viral Infections 2004, 515-534. Marcel Dekker, Inc., New York. second ed. Lennette (Ed.).
8. de Jong J.C., Ronde-Verloop F.M., Veenendaal-van Herk T.M., Weijers T.F., Bijlsma K., Osterhaus A.D. Antigenic heterogeneity within influenza A (H3N2) virus strains. Bull World Health Organ 1988, 66:47-55.
9. Note for Guidance on Harmonisation of Requirements for Influenza Vaccines 1997, European agency for the evaluation of medicinal products (EMEA), London, UK.
10. de Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Dev. Biol. (Basel) 2003, 115:63-73.
11. Beyer W.E., Palache A.M., Sprenger M.J., Hendriksen E., Tukker J.J., Darioli R., et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996, 14:1331-1339.
12. Nabeshima S., Kashiwagi K., Murata M., Kanamoto Y., Furusyo N., Hayashi J. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J. Med. Virol. 2007, 79:320-325.
13. Park M.A., Li J.T., Hagan J.B., Maddox D.E., Abraham R.S. Common variable immunodeficiency: a new look at an old disease. Lancet 2008, 372:489-502.
14. Park M.A., Li J.T., Hagan J.B., Maddox D.E., Abraham R.S. Common variable immunodeficiency: a new look at an old disease. Lancet 2008, 372:489-502.
15. Scheiermann N., Kuwert E.K. Studies on human immunoglobulin preparations: I. Viral antibody profiles (author's transl). Med. Klin. 1979, 74:820-824.
16. Weeke-Luttmann M., Schmidt I., Fenyves A., von Wangenheim G., Fischer L. Neutralizing virus antibodies in human immunoglobulins for intravenous use. Immun. Infekt. 1984, 12:201-207.
17. Rimmelzwaan G.F., de Jong J.C., Donker G.A., Meijer A., Fouchier R.A., Osterhaus A.D. The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season. Ned Tijdschr Geneeskd 2006, 150:2209-2214.
18. Kendal A.P., Cate T.R. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J. Clin. Microbiol. 1983, 18:930-934.
19. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006, 55:1-42.
20. Esposito S., Marchisio P., Cavagna R., Gironi S., Bosis S., Lambertini L., et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003, 21:3162-3168.
21. Ghendon Y.Z., Kaira A.N., Elshina G.A. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol. Infect. 2006, 134:71-78.
22. Jefferson T., Demicheli V., Rivetti D., Jones M., Di Pietrantonj C., Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006, 367:303-313.
23. Poland G.A., Jacobson R.M., Ovsyannikova I.G. Influenza virus resistance to antiviral agents: a plea for rational use. Clin. Infect. Dis. 2009.
24. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.